Source: Revive Therapeutics Ltd.
  • Revive Therapeutics (RVV) has closed a private placement for gross proceeds of $4.3 million
  • The company issued 28,676,064 units priced at C$0.15 per unit
  • The company paid finders fees totalling $304,112.75 in cash and 2,294,085 finder warrants
  • Revive is a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders
  • Revive Therapeutics Ltd. (RVV) opened trading at C$0.13

Revive Therapeutics (RVV) has closed its previously-announced private placement for gross proceeds of$4,301,409.

The company issued a total of 28,676,064 units for $0.15 per unit. Each unit consists of one common share and one common share purchase warrant.  Each warrant entitles the holder to acquire one additional common share for a period of three years from the closing date of the offering.

The company paid $304,112.75 in cash and 2,294,085 finder warrants to EMD Financial Inc. and other registrants.

The offering is subject to the receipt of all necessary regulatory approvals.

Revive is a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders.

Revive Therapeutics Ltd. (RVV) opened trading at C$0.13.


More From The Market Online

Usha Resources begins phase 4 fieldwork at White Willow Project

Usha Resources (TSXV:USHA) has begun the fourth phase of fieldwork at its White Willow Lithium Project in Ontario following phase 3 work.

@ the Bell: Stocks level-out ahead of Easter long weekend

A rebound in oil prices and growth in metal prices helped push Canada’s main stock index higher as investors await economic data.